The widespread transmission and evolution of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) call for rapid nucleic acid diagnostics that are easy to use outside of …

Background Nirmatrelvir/ritonavir, the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
protease inhibitor, reduces the risk of hospitalization and death by …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing an exponentially
increasing number of coronavirus disease 19 (COVID-19) cases globally. Prioritization of …

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic expanded,
it was clear that effective testing for the presence of neutralizing antibodies in the blood of …

Sangivamycin is a nucleoside analog that is well tolerated by humans and broadly active
against phylogenetically distinct viruses, including arenaviruses, filoviruses, and …

Despite more than 300,000 rVSVΔG-ZEBOV-glycoprotein (GP) vaccine doses having been
administered during Ebola virus disease (EVD) outbreaks in the Democratic Republic of the …

The COVID-19 pandemic, and the recent rise and widespread transmission of SARS-CoV-2
Variants of Concern (VOCs), have demonstrated the need for ubiquitous nucleic acid testing …

Clinical rebound of COVID-19 after nirmatrelvir/ritonavir treatment has been reported. We
performed clinical, virologic, and immune measurements in seven patients with symptomatic …

Prior to the release from BSL-3 or -4 laboratories, materials from which nucleic acids are to
be extracted must be rendered noninfectious. Typically, phenol/guanidine thiocyanate …

Antibody-mediated cancer immunotherapy targets inhibitory surface molecules, such as
PD1, PD-L1, and CTLA-4, aiming to re-invigorate dysfunctional T cells. We purified and …